The HARMONY-7 trial utilized a Diabetes Medication Satisfaction questionnaire, and demonstrated that treatment satisfaction scores improved from baseline for both the liraglutide and albiglutide groups (4.38 for liraglutide and 3.29 for albiglutide), with no significant differences between groups ( p = 0.207) [Pratley et al
The GLP-1s are FDA-approved
Beyond obesity research, 5-Amino-1MQ has also been explored in studies involving regenerative biology, cellular senescence, fibrosis, and cancer metabolism, where NNMT expression has been associated with altered cellular metabolic states
The most common side effects are shortlived gastrointestinal symptoms
Greens + Reds Powerful antioxidant and micronutrient support for cellular repair, digestion, and detoxification
Foundayo offers maximum flexibility for patients who want an oral option with no dosing restrictions